Literature DB >> 11774072

Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.

Andrea L Vincent1, Gail Billingsley, Yvonne Buys, Alex V Levin, Megan Priston, Graham Trope, Donna Williams-Lyn, Elise Héon.   

Abstract

"Early-onset glaucoma" refers to genetically heterogeneous conditions for which glaucoma manifests at age 5-40 years and for which only a small subset is molecularly characterized. We studied the role of MYOC, CYP1B1, and PITX2 in a population (n=60) affected with juvenile or early-onset glaucoma from the greater Toronto area. By a combination of single-strand conformation polymorphism and direct cycle sequencing, MYOC mutations were detected in 8 (13.3%) of the 60 individuals, CYP1B1 mutations were detected in 3 (5%) of the 60 individuals, and no PITX2 mutations were detected. The range of phenotypic expression associated with MYOC and CYP1B1 mutations was greater than expected. MYOC mutations included cases of juvenile glaucoma with or without pigmentary glaucoma and mixed-mechanism glaucoma. CYP1B1 mutations involved cases of juvenile open-angle glaucoma, as well as cases of congenital glaucoma. The study of a family with autosomal dominant glaucoma showed the segregation of both MYOC and CYP1B1 mutations with disease; however, in this family, the mean age at onset of carriers of the MYOC mutation alone was 51 years (range 48-64 years), whereas carriers of both the MYOC and CYP1B1 mutations had an average age at onset of 27 years (range 23-38 years) (P=.001). This work emphasizes the genetic heterogeneity of juvenile glaucoma and suggests, for the first time, that (1) congenital glaucoma and juvenile glaucoma are allelic variants and (2) the spectrum of expression of MYOC and CYP1B1 mutations is greater than expected. We also propose that CYP1B1 may act as a modifier of MYOC expression and that these two genes may interact through a common pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774072      PMCID: PMC384919          DOI: 10.1086/338709

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  67 in total

1.  Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment.

Authors:  M P Fautsch; C K Bahler; D J Jewison; D H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.

Authors:  B A Bejjani; D W Stockton; R A Lewis; K F Tomey; D K Dueker; M Jabak; W F Astle; J R Lupski
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

3.  The etiology, symptomatology, and treatment of juvenile glaucoma.

Authors:  O H ELLIS
Journal:  Am J Ophthalmol       Date:  1948-12       Impact factor: 5.258

4.  A cellular assay distinguishes normal and mutant TIGR/myocilin protein.

Authors:  Z Zhou; D Vollrath
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432.

Authors:  T Shimada; J Watanabe; K Inoue; F P Guengerich; E M Gillam
Journal:  Xenobiotica       Date:  2001-03       Impact factor: 1.908

6.  Functional analyses of two newly identified PITX2 mutants reveal a novel molecular mechanism for Axenfeld-Rieger syndrome.

Authors:  M Priston; K Kozlowski; D Gill; K Letwin; Y Buys; A V Levin; M A Walter; E Héon
Journal:  Hum Mol Genet       Date:  2001-08-01       Impact factor: 6.150

7.  Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium.

Authors:  R Allikmets
Journal:  Am J Hum Genet       Date:  2000-07-03       Impact factor: 11.025

8.  Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene.

Authors:  W L Alward; E V Semina; J W Kalenak; E Héon; B P Sheth; E M Stone; J C Murray
Journal:  Am J Ophthalmol       Date:  1998-01       Impact factor: 5.258

Review 9.  Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.

Authors:  M Ingelman-Sundberg
Journal:  Mutat Res       Date:  2001-10-01       Impact factor: 2.433

Review 10.  Primary infantile glaucoma (congenital glaucoma).

Authors:  V P deLuise; D R Anderson
Journal:  Surv Ophthalmol       Date:  1983 Jul-Aug       Impact factor: 6.048

View more
  107 in total

Review 1.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

2.  CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.

Authors:  Fereshteh Chitsazian; Betsabeh Khoramian Tusi; Elahe Elahi; Heidar Amini Saroei; Mohammad H Sanati; Shahin Yazdani; Mohammad Pakravan; Navid Nilforooshan; Yadollah Eslami; Mohammad Ali Zare Mehrjerdi; Reza Zareei; Mahmood Jabbarvand; Ali Abdolahi; Ali R Lasheyee; Arash Etemadi; Behnaz Bayat; Mehdi Sadeghi; Mohammad M Banoei; Behnam Ghafarzadeh; Mohammad R Rohani; Akram Rismanchian; Yvonne Thorstenson; Mansoor Sarfarazi
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

3.  Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.

Authors:  J Vázquez-Mellado; V Alvarado-Romano; R Burgos-Vargas; A L Jiménez-Vaca; G Pozo-Molina; S A Cuevas-Covarrubias
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

4.  Complex genetics of glaucoma: defects in CYP1B1, and not MYOC, cause pathogenesis in an early-onset POAG patient with double variants at both loci.

Authors:  Moulinath Acharya; Arijit Mukhopadhyay; Ashima Bhattacharjee; Sanjay K D Thakur; Arun K Bandyopadhyay; Kunal Ray
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 5.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

Review 6.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

Review 7.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

8.  Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.

Authors:  Kate E Keller; Yong-Feng Yang; Ying Ying Sun; Renee Sykes; Natalie Donna Gaudette; John R Samples; Ted S Acott; Mary K Wirtz
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

9.  Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in Qatar.

Authors:  Juan L Rodriguez-Flores; Khalid Fakhro; Neil R Hackett; Jacqueline Salit; Jennifer Fuller; Francisco Agosto-Perez; Maey Gharbiah; Joel A Malek; Mahmoud Zirie; Amin Jayyousi; Ramin Badii; Ajayeb Al-Nabet Al-Marri; Lotfi Chouchane; Dora J Stadler; Jason G Mezey; Ronald G Crystal
Journal:  Hum Mutat       Date:  2013-11-10       Impact factor: 4.878

Review 10.  Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes.

Authors:  A M Slavotinek; C J Tifft
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.